{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:02:34Z","timestamp":1768971754735,"version":"3.49.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,5,1]]},"DOI":"10.1093\/ndt\/gfk058","type":"journal-article","created":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T01:29:07Z","timestamp":1138066147000},"page":"1389-1394","source":"Crossref","is-referenced-by-count":50,"title":["A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period"],"prefix":"10.1093","volume":"21","author":[{"suffix":"Jr","given":"Richard N.","family":"Formica","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc I.","family":"Lorber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Douglas","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret J.","family":"Bia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,1,24]]},"reference":[{"key":"key\n\t\t\t\t20171012174300_BIB1","doi-asserted-by":"crossref","unstructured":"Neaton JD, Grimm RH, Prineas RJ et al. Treatment of Mild Hypertension Study: final results. Treatment of Mild Hypertension Study Research Group. JAMA1993; 270: 713\u2013724","DOI":"10.1001\/jama.270.6.713"},{"key":"key\n\t\t\t\t20171012174300_BIB2","doi-asserted-by":"crossref","unstructured":"Torregrosa JV, Campistol JM, Montesinos M, Rogada AG, Oppenheimer F, Andreu J. Efficacy of captopril on post-transplant erythrocytosis. Transplantation1994; 58: 311\u2013314","DOI":"10.1097\/00007890-199408150-00010"},{"key":"key\n\t\t\t\t20171012174300_BIB3","doi-asserted-by":"crossref","unstructured":"Perazella M, McPhedran P, Kliger A, Lorber M, Levy E, Bia MJ. Enalapril treatment of post-transplant erythrocytosis: efficacy independent of circulating erythropoietin levels. Am J Kidney Dis1995; 26: 495\u2013500","DOI":"10.1016\/0272-6386(95)90496-4"},{"key":"key\n\t\t\t\t20171012174300_BIB4","doi-asserted-by":"crossref","unstructured":"Calvino J, Lens XM, Romero R, Sanchez-Guisande D. Long-term anti-proteinuric effect of losartan in renal transplant recipients treated for hypertension. Nephrol Dial Transplant2000; 15: 82\u201386","DOI":"10.1093\/ndt\/15.1.82"},{"key":"key\n\t\t\t\t20171012174300_BIB5","doi-asserted-by":"crossref","unstructured":"Stigant CE, Cohen J, Vivera M, Zaltzman JS. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy. Am J Kidney Dis2000; 35: 58\u201363","DOI":"10.1016\/S0272-6386(00)70302-7"},{"key":"key\n\t\t\t\t20171012174300_BIB6","doi-asserted-by":"crossref","unstructured":"Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med2003; 115: 41\u201346","DOI":"10.1016\/S0002-9343(03)00158-X"},{"key":"key\n\t\t\t\t20171012174300_BIB7","doi-asserted-by":"crossref","unstructured":"Thomas MC, Cooper ME. Blockade of the renin\u2013angiotensin system: better late than never. Am J Kidney Dis2004; 43: 1113\u20131115","DOI":"10.1053\/j.ajkd.2004.03.038"},{"key":"key\n\t\t\t\t20171012174300_BIB8","doi-asserted-by":"crossref","unstructured":"Artz MA, Hilbrands LB, Borm G, Assmann GB, Wetzels JFM. Blockade of the renin\u2013angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant2004; 19: 2852\u20132857","DOI":"10.1093\/ndt\/gfh462"},{"key":"key\n\t\t\t\t20171012174300_BIB9","doi-asserted-by":"crossref","unstructured":"Lin J, Valeri AM, Markowitz GS, D\u2019Agati VD, Cohen DJ, Radhakrishan J. Angiotensin converting enzyme inhibition in chronic allograft nephropathy. Transplantation2002; 73: 783\u2013788","DOI":"10.1097\/00007890-200203150-00022"},{"key":"key\n\t\t\t\t20171012174300_BIB10","doi-asserted-by":"crossref","unstructured":"Holgado R, Anaya F, Del Castillo DD. Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation. Nephrol Dial Transplant2001; 16 [Suppl 1]: 82\u201386","DOI":"10.1093\/ndt\/16.suppl_1.117"},{"key":"key\n\t\t\t\t20171012174300_BIB11","doi-asserted-by":"crossref","unstructured":"Inigo P, Campistol JM, Jimenez W et al. Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-\u03b21 plasma levels in a crossover trial in renal transplant recipients. J Am Soc Nephrol2001; 12: 822\u2013827","DOI":"10.1681\/ASN.V124822"},{"key":"key\n\t\t\t\t20171012174300_BIB12","doi-asserted-by":"crossref","unstructured":"Ersoy A, Dilek K, Usta M et al. Angiotensin II receptor antagonist losartan reduces microalbuminuria in hypertensive renal transplant recipients. Clin Transplant2002; 16: 202\u2013205","DOI":"10.1034\/j.1399-0012.2002.01127.x"},{"key":"key\n\t\t\t\t20171012174300_BIB13","doi-asserted-by":"crossref","unstructured":"El-Aroundy AE, Hassan NA, Foda MA et al. Effect of angiotensin II receptor blocker on plasma levels of TGF-\u03b21 and interstitial fibrosis in hypertensive kidney transplant patients. Am J Nephrol2003; 23: 300\u2013306","DOI":"10.1159\/000072820"},{"key":"key\n\t\t\t\t20171012174300_BIB14","doi-asserted-by":"crossref","unstructured":"Midtvedt K, Hartmann A, Foss A et al. Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. Transplantation2001; 72: 1787","DOI":"10.1097\/00007890-200112150-00013"},{"key":"key\n\t\t\t\t20171012174300_BIB15","doi-asserted-by":"crossref","unstructured":"Formica RN, Friedman AL, Lorber MI, Bia MJ. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early post transplant period. Transplantation Proc2004; 36: 2675\u20132678","DOI":"10.1016\/j.transproceed.2004.10.013"},{"key":"key\n\t\t\t\t20171012174300_BIB16","unstructured":"Hestin D, Mertes PM, Hubert J et al. Relationship between blood pressure and rennin, angiotensin II and atrial natriuretic factor after renal transplantation. Clin Nephrol1997; 103: 98\u2013103"},{"key":"key\n\t\t\t\t20171012174300_BIB17","doi-asserted-by":"crossref","unstructured":"Kamel KS, Ethier JH, Quaggin S et al. Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine. J Am Soc Nephrol1992; 2: 1279\u20131284","DOI":"10.1681\/ASN.V281279"},{"key":"key\n\t\t\t\t20171012174300_BIB18","unstructured":"Weidekamm C, Hauser P, Hansmann C et al. Effects of AT1 and AT2 receptor blockade on angiotensin II induced apoptosis of human renal proximal tubular epithelial cells. Wien Klin Wochenschr2002; 114: 725"},{"key":"key\n\t\t\t\t20171012174300_BIB19","doi-asserted-by":"crossref","unstructured":"Bhaskaran M, Reddy K, Radhakrishanan N, Franki N, Ding G, Singhal PC. Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol2003; 284: F955\u2013F965","DOI":"10.1152\/ajprenal.00246.2002"},{"key":"key\n\t\t\t\t20171012174300_BIB20","doi-asserted-by":"crossref","unstructured":"Palmer BF. Managing hyperkalemia caused by inhibitors of the renin\u2013angiotensin\u2013aldosterone system. N Engl J Med2004; 351: 585\u2013592","DOI":"10.1056\/NEJMra035279"},{"key":"key\n\t\t\t\t20171012174300_BIB21","doi-asserted-by":"crossref","unstructured":"Bakris GL, Weir MR. Angiotensin converting enzyme inhibitor associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med2000; 160: 685\u2013693","DOI":"10.1001\/archinte.160.5.685"},{"key":"key\n\t\t\t\t20171012174300_BIB22","doi-asserted-by":"crossref","unstructured":"Taal MW, Brenner BM. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int2000; 57: 1803\u20131817","DOI":"10.1046\/j.1523-1755.2000.00031.x"},{"key":"key\n\t\t\t\t20171012174300_BIB23","doi-asserted-by":"crossref","unstructured":"Wang AY, Yu AW, Lam CW et al. Effects of losartan or enalapril on hemoglobin, circulating erythropoietin and insulin like growth factor-1\u2009in patients with and without posttransplant erythrocytosis. Am J Kidney Dis2002; 39: 600\u2013608","DOI":"10.1053\/ajkd.2002.31404"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/21\/5\/1389\/6901038\/gfk058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:36:32Z","timestamp":1627000592000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/21\/5\/1389\/1822188\/A-randomized-trial-comparing-losartan-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,24]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,1,24]]},"published-print":{"date-parts":[[2006,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfk058","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,5]]},"published":{"date-parts":[[2006,1,24]]}}}